Effect of cold storage on the haemostatic cascade systems

Transfusion Science

Volumn 17, Issue 3, 1996, Pages 407-414

  Omran, S ^a   Hallouda, M ^a   Essawi, R ^a   El Attar, I ^b   Aboul Enein, A ^c   Gaafar, T ^c   Afifi, N ^c  

^a Imbaba   (Egypt)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; CITRIC ACID; COMPLEMENT COMPONENT C1S INHIBITOR; FRESH FROZEN PLASMA; GLUCOSE; KALLIKREIN; PHOSPHATE; PLASMINOGEN;

ARTICLE; BLOOD CLOTTING; BLOOD STORAGE; CRYOPRESERVATION; ERYTHROCYTE; HEMOSTASIS; HUMAN; KALLIKREIN KININ SYSTEM; NORMAL HUMAN;

EID: 0345879080     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-3886(96)00023-9     Document Type: Article

References (21)

1. st edn., U.S.A., Canada, Australia, Blackwell Scientific Publications, 1987, p. 15.
2. Hellgren M, Egberg N, Eklund J: Blood coagulation factors and their inhibitors in critically ill patients. Intensive Care Med 1984; 10:23-28.
3. Blomback M, Chmielewska J, Netre C, Akerblom O: Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma. Vox Sang 1984; 47:335-342.
4. Abildgaard U, Lie M, Odegaard OR: Antithrombin (heparin cofactor) assay with 'new' chromogenic substrates. Thrombosis Res 1977; 11:549-553.
5. Pelzer H, Schwarz A, Heinburger N: Determination of human thrombinantithrombin complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59:101-106.
6. Silverstein RM: The determination of human plasminogen using NA-CBZLysine paranitrophenyl ester as a substrate. Analyt Biochem 1975; 65: 500-506.
7. Aoki N: Fibrinolytic states of alpha 2 plasmin inhibitor. Blood 1980; 55: 483-489.
8. Bounameaux H, Schneider PA, Reber G, De Moerloose P, Krahenbahl B: Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol 1989; 91:82-85.
9. Martinoli JL, Guichaoua JF: Chromogenic substrates: A new generation. Proc of the 9th CISH and 17th ISBT, Budapest, 1982.
10. Steif TW, Acob A, Heinburg N: Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III and C1-inhibitor. Thrombosis Res 1988; 4916:581-589.
11. Armitage P, Berry G: Statistical Methods in Medical Research, 2nd edn. Oxford, Blackwell Scientific Publications, 1987.
12. Cody RP, Smith JK: Applied Statistics and the SAS Programming Language, 3rd edn, New York, North-Holland, 1991.
13. Hondow JA, Russel WJ, Duncan BM, Lloyd JV: The stability of coagulation factors in stored blood. Aust NZJ Surg 1982; 52(3):265-269.
14. Carr JM: Disseminated intravascular coagulation in cirrhosis. Hepatology 1989; 10:103-110.
15. Prisco D, Bonechi P, Boddi M, Tramontana M, Fortini A: Thrombinantithrombin III complexes in hypercoagulable states. Thrombosis Haemost 1989;62(1):449.
16. Deguchi K, Noguchi M, Yuwasaki E, Endou T, Deguchi A, Wade H, Murashime S, Nishikawa M, Shirakawa S, Tanaka K, Kusagawa M: Dynamic fluctuation in blood of thrombin/ antithrombin complex (TAT). Am J Haematol 1991; 38:86-89.
17. Takahashi H, Tatewaki W, Wada K, Yoshikawa A, Shibata A: Thrombin and plasmin generation in patients with liver disease. Am J Haematol 1989; 32:30-5.
18. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA: A comparative evaluation of assays for markers of activated coagulation and/ or fibrinolysis: Thrombin-antithrombin complex, D-dimer and fibrinogen/flbrin fragment E antigen. Br J Haematol 1990; 74:471-479.
19. Czendlik C, Lammle B, Duckert F: Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Thromb Haemost 1985; 11:242-244.
20. Hutton RA: Normal haemostasis, in Hoffbrand AV and Lewis SM (eds): Postgraduate Haematology. Oxford, London, Heinemann 1989, pp. 560-594.
21. Mamsteva GI, Fedorov NA, Ovcharuk IN: Functional activity of thrombocytes and granulocytes of donor blood after selective removal of fibronectin. Vestn Adad Med Nauk USSR 1991, 2:45-46.